NEXT Biometrics Group ASA
NXTBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6,287 | $3,310 | $4,741 | $5,639 |
| % Growth | 89.9% | -30.2% | -15.9% | – |
| Cost of Goods Sold | $2,847 | $7,108 | $7,565 | $10,033 |
| Gross Profit | $85 | -$3,798 | -$2,824 | -$4,394 |
| % Margin | 1.4% | -114.7% | -59.6% | -77.9% |
| R&D Expenses | $366 | $886 | $562 | $623 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,927 | $2,196 | $1,724 | $2,172 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$234 | $5 | -$708 |
| Operating Expenses | $4,293 | $2,848 | $2,282 | $3,503 |
| Operating Income | -$4,047 | -$6,646 | -$5,105 | -$7,897 |
| % Margin | -64.4% | -200.8% | -107.7% | -140% |
| Other Income/Exp. Net | $90 | $216 | $376 | $1,283 |
| Pre-Tax Income | -$3,956 | -$6,430 | -$4,730 | -$6,614 |
| Tax Expense | $17 | $23 | -$6 | $183 |
| Net Income | -$3,973 | -$6,453 | -$4,724 | -$6,797 |
| % Margin | -63.2% | -195% | -99.6% | -120.5% |
| EPS | -0.037 | -0.068 | -0.052 | -0.076 |
| % Growth | 45.3% | -31.7% | 32.4% | – |
| EPS Diluted | -0.037 | -0.068 | -0.052 | -0.076 |
| Weighted Avg Shares Out | 107,220 | 95,151 | 91,792 | 89,246 |
| Weighted Avg Shares Out Dil | 107,220 | 95,151 | 91,792 | 89,246 |
| Supplemental Information | – | – | – | – |
| Interest Income | $130 | $90 | $73 | $80 |
| Interest Expense | $10 | $0 | $12 | $147 |
| Depreciation & Amortization | $474 | $694 | $737 | $801 |
| EBITDA | -$3,471 | -$5,730 | -$4,170 | -$5,666 |
| % Margin | -55.2% | -173.1% | -87.9% | -100.5% |